Translation and Transcultural Adaptation of the Arm Activity Measure (ArmA) and Motor Activity Log (MAL)
F-ArmA
1 other identifier
observational
60
1 country
1
Brief Summary
Upper limb impairment occurs in approximately 70 to 80 per cent of adults post stroke. These impairments will have consequences on functional performance in activities of daily living and hence quality of life. Assessment of upper limb function is a component of rehabilitation that contributes to the selection of optimal interventions according to patient individualized needs. The Arm Activity Measure (ArmA) provides a standardized assessment of upper limb passive and active perceived performance that is only available in it's English version. The aim of this study is to translate and conduct a cross-cultural adaptation of the ArmA is order to investigate its psychometric properties through a validation study among stroke patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 9, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 9, 2021
CompletedFirst Submitted
Initial submission to the registry
February 10, 2021
CompletedFirst Posted
Study publicly available on registry
February 15, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
February 9, 2023
CompletedFebruary 15, 2021
February 1, 2021
Same day
February 10, 2021
February 10, 2021
Conditions
Outcome Measures
Primary Outcomes (2)
Measure OF ArmA inter-rater (test-retest) reproducibility values as measured by intra class coefficients ICC2
The primary outcome measure will be ArmA inter-rater (test-retest) reproducibility values as measured by intra class coefficients ICC2,1. Data collection on perceived upper limb performance with the two-step F-ArmA measurement (T0 and T1) will allow the primary outcome (ICC2,1) to be calculated to establish inter-rater reproducibility. ArmA and MAL will be administered on 3 separate occasions by 2 separate assessors.
first day of hospitalisation
Measure OF ArmA inter-rater (test-retest) reproducibility values as measured by intra class coefficients ICC2
A secondary independent assessor (E2) will assess ArmA and MAL
2 to 7 days of first assessment (T0)
Study Arms (2)
subacute phase
between 7 days and 6 months post-stroke;
chronic phase
minimum 6 months post-stroke
Interventions
The Arm Activity Measure (ArmA) provides a standardized assessment of upper limb passive and active perceived performance
Eligibility Criteria
adults with subacute and chronic stroke
You may qualify if:
- age \> 18 with principle diagnosis of first-time ischemic or hemorrhagic stroke at least 7 days since onset and confirmed by MRI or CT;
- participant having returned home from hospitalization at least one night if stroke time since onset is \<6 months or resides at home if \>6 months since stroke onset;
- participant can maintain attention for questions for at least 30 minutes;
- motivation to participate and having given informed written consent.
You may not qualify if:
- subscale of aphasia severity from the Boston Diagnostic Aphasia Examination ≤3 indicating insufficient comprehension and expression for testing;
- subscale score of ≥2 on the agnosia Unilateral Negligence Assessment Battery (BEN) indicating unilateral neglect.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UHToulouse
Toulouse, 31000, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Claire VILLEPINTE
University Hospital, Toulouse
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 10, 2021
First Posted
February 15, 2021
Study Start
February 9, 2021
Primary Completion
February 9, 2021
Study Completion
February 9, 2023
Last Updated
February 15, 2021
Record last verified: 2021-02